Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
61.84
+0.40 (0.64%)
Aug 31, 2026, 10:52 AM EDT - Market open

Inspire Medical Systems Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
135.04145.4253.51-21.15-44.88-42.04
Depreciation & Amortization
17.2113.966.552.851.861.22
Loss (Gain) From Sale of Investments
-5.34-2.89-8.86-2.47-00.01
Stock-Based Compensation
119.39130.26116.0182.4751.9726.48
Provision & Write-off of Bad Debts
0.20.2-0.771.61-0.06-
Other Operating Activities
-72.07-82.591.522.130.881.07
Change in Accounts Receivable
34.3-26.23-2.6-30.22-27.02-9.24
Change in Inventory
-48.82-65.18-46.23-225.35-8.75
Change in Accounts Payable
-22.26-3.750.69.314.364.78
Change in Other Net Operating Assets
-0.577.7710.522.149.136.36
Operating Cash Flow
157.07116.98130.2524.6511.57-20.12
Operating Cash Flow Growth
33.74%-10.19%428.32%113.09%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-39.98-38.5-39.12-23.63-9.1-4.67
Investment in Securities
8.7259.95-74-271.19-10.533.81
Investing Cash Flow
-31.2621.45-113.12-294.82-19.629.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----24.5-
Net Debt Issued (Repaid)
-----24.5-
Issuance of Common Stock
5.4514.6127.7731.11259.6214.95
Repurchase of Common Stock
-110.41-198.06-80.17-17.16-0.04-
Financing Cash Flow
-104.96-183.45-52.3913.95235.0814.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.02-0.31-0.120.160.08-0.02
Net Cash Flow
20.83-45.34-35.39-256.06227.1323.95

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
117.0978.4891.121.022.47-24.79
Free Cash Flow Growth
37.74%-13.88%8798.73%-58.59%--
Free Cash Flow Margin
13.03%8.61%11.35%0.16%0.61%-10.62%
Free Cash Flow Per Share
3.992.642.980.040.09-0.91
Levered Free Cash Flow
94.6454.562.720.0317.43-10.69
Unlevered Free Cash Flow
94.7254.5962.730.0318.48-9.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.140.140.02-2.321.89
Change in Working Capital
-37.35-87.38-37.71-40.781.81-6.86
SEC Filings: 10-K · 10-Q